Document Classification

Section Type: RESULTS

Text: On a patient-by-patient basis, MRSI had 92. 3 % sensitivity, 88. 2 % specificity, 85. 7 % positive predictive value (PPV), 93. 7 % negative predictive value (NPV), and 90 % accuracy ; DCEMR had 84. 6 % sensitivity, 82. 3 % specificity, 78. 5 % PPV, 87. 5 % NPV, and 83. 3 % accuracy ; and the association MRSI plus DCEMR had 92. 6 % sensitivity, 88. 8 % specificity, 88. 7 % PPV, 92. 7 % NPV, and 90. 7 % accuracy, for predicting prostate cancer detection.